PR-domain - containing Mds1-Evi1 is critical for long-term hematopoietic stem cell function

Blood

Volumn 118, Issue 14, 2011, Pages 3853-3861

  Zhang, Yi ^a   Stehling Sun, Sandra ^b   Lezon Geyda, Kimberly ^c   Juneja, Subhash C ^a   Coillard, Lucie ^a   Chatterjee, Gouri ^c   Wuertzer, Charles A ^a   Camargo, Fernando ^b   Perkins, Archibald S ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; CYCLIN DEPENDENT KINASE INHIBITOR 1C; PROTEIN P57;

ANIMAL CELL; ARTICLE; CELL FUNCTION; ECOTROPIC PROVIRAL INTEGRATION SITE 1 GENE; EXON; GENE; GENETIC ANALYSIS; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; IMMUNOPHENOTYPING; LEUKOCYTOSIS; MOUSE; MYELODYSPLASTIC SYNDROME 1 GENE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA SEQUENCE; THROMBOCYTOPENIA;

EID: 80053653651     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-02-334680     Document Type: Article

References (44)

1. Morrison S, Uchida N, Weissman I. The biology of hematopoietic stem cells. Annu Rev Cell Dev Biol. 1995;11:35-71. (Pubitemid 26019601)
2. Hodgson G, Bradley T, Radley J. The organization of hemopoietic tissue as inferred from the effects of 5-fluorouracil. Exp Hematol. 1982;10(1):26-35. (Pubitemid 12162626)
3. Lerner C, Harrison D. 5-Fluorouracil spares hemopoietic stem cells responsible for long-term repopulation. Exp Hematol. 1990;18(2):114-118. (Pubitemid 20072292)
4. Harrison D, Lerner C. Most primitive hematopoietic stem cells are stimulated to cycle rapidly after treatment with 5-fluorouracil. Blood. 1991;78(5):1237-1240.
5. Randall T, Weissman I. Phenotypic and functional changes induced at the clonal level in hematopoietic stem cells after 5-fluorouracil treatment. Blood. 1997;89(10):3596-3606. (Pubitemid 27227082)
6. Wilson A, Laurenti E, Oser G, et al. Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair. Cell. 2008;135(6):1118-1129.
7. Cheng T, Rodrigues N, Shen H, et al. Hematopoietic stem cell quiescence maintained by p21cip1/waf1. Science. 2000;287(5459):1804-1808.
8. Yilmaz Ö, Valdez R, Theisen BK, et al. Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature. 2006;441(7092):475-482. (Pubitemid 44050144)
9. Zhang J, Grindley JC, Yin T, et al. PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention. Nature. 2006;441(7092):518-522. (Pubitemid 44050154)
10. Zeng H, Yücel R, Kosan C, Klein-Hitpass L, Möröy T. Transcription factor Gfi1 regulates self-renewal and engraftment of hematopoietic stem cells. EMBO J. 2004;23(20):4116-4125. (Pubitemid 39472432)
11. Harrison DE, Astle CM. Loss of stem cell repopulating ability upon transplantation. Effect of donor age, cell number and transplantation procedure. J Exp Med. 1982;156(6):1767-1779. (Pubitemid 13167420)
12. Janzen V, Forkert R, Fleming HE, et al. Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a. Nature. 2006;443(7110):421-426. (Pubitemid 44477274)
13. Tothova Z, Kollipara R, Huntly B, et al. FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell. 2007;128(2):325-339. (Pubitemid 46137992)
14. Wilson A, Laurenti E, Trumpp A. Balancing dormant and self-renewing hematopoietic stem cells. Curr Opin Genet Dev. 2009;19(5):461-468.
15. Morishita K, Parker DS, Mucenski ML, Jenkins NA, Copeland NG, Ihle JN. Retroviral activation of a novel gene encoding a zinc finger protein in IL3-dependent myeloid leukemia cell lines. Cell. 1988;54(6):831-840.
16. Levy ER, Parganas E, Morishita K, et al. DNA rearrangements proximal to the EVI1 locus associated with the 3q21q26 syndrome. Blood. 1994;83(5):1348- 1354. (Pubitemid 24062858)
17. Keller A, Maniatis T. Identification and characterization of a novel repressor of beta-interferon gene expression. Genes Dev. 1991;5(5):868-879. (Pubitemid 21906003)
18. Turner CJ, Mack D, Davis M. Blimp-1, a novel zinc finger-containing protein that can drive the maturation of B lymphocytes into immunoglobulin- secreting cells. Cell. 1994;77(2):297-306. (Pubitemid 24138626)
19. Buyse I, Shao G, Huang S. The retinoblastoma protein binds to RIZ, a zinc-finger protein that shares an epitope with the adenovirus E1A protein. Proc Natl Acad Sci U S A. 1995;92(10):4467-4471.
20. Yuasa H, Oike Y, Iwama A, et al. Oncogenic transcription factor Evi1 regulates hematopoietic stem cell proliferation through GATA-2 expression. EMBO J. 2005;24(11):1976-1987. (Pubitemid 40896169)
21. Phillips R, Ernst R, Brunk B, et al. The genetic program of hematopoietic stem cells. Science. 2000;288(5471):1635-1637.
22. Shimizu S, Nagasawa T, Katoh O, Komatsu N, Yokota J, Morishita K. EVI1 is expressed in megakaryocyte cell lineage and enforced expression of EVI1 in UT-7/GM cells induces megakaryocytic differentiation. Biochem Biophys Res Comm. 2002;292(3):609-616. (Pubitemid 34681103)
23. Park I-K, He Y, Lin F, et al. Differential gene expression profiling of adult murine hematopoietic stem cells. Blood. 2002;99(2):488-498. (Pubitemid 34533083)
24. Goyama S, Yamamoto G, Shimabe M, et al. Evi-1 is a critical regulator for hematopoietic stem cells and transformed leukemic cells. Cell Stem Cell. 2008;3(2):207-220.
25. Cheshier S, Morrison S, Liao X, Weissman I. In vivo proliferation and cell cycle kinetics of long-term self-renewing hematopoietic stem cells. Proc Natl Acad Sci U S A. 1999;96(6):3120-3125. (Pubitemid 29148854)
26. Osawa M, Hanada K, Hamada H, Nakauchi H. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic cell. Science. 1996;273(5272):242-245. (Pubitemid 26285891)
27. McNiece I, Bradley T, Kriegler A, Hodgson G. A growth factor produced by WEHI-3 cells for murine high proliferative potential GM-progenitor colony forming cells. Cell Biol Int Rep. 1982;6(3):243-251. (Pubitemid 12155763)
28. Hoyt P, Bartholomew C, Davis A, et al. The Evi1 proto-oncogene is required at midgestation for neural, heart, and paraxial mesenchyme development. Mech Dev. 1997;65(1-2):55-70. (Pubitemid 27314591)
29. Kiel M, Yilmaz O, Iwashita T, Terhorst C, Morrison S. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell. 2005;121(7):1109-1121. (Pubitemid 40884400)
30. Papathanasiou P, Attema J, Karsunky H, Xu J, Smale S, Weissman I. Evaluation of the long-term reconstituting subset of hematopoietic stem cells with CD150. Stem Cells. 2009;27(10):2498-2508.
31. McNiece I, Bertoncello I, Kriegler A, Quesenberry P. Colony-forming cells with high proliferative potential (HPP-CFC). Int J Cell Cloning. 1990;8(3):146-160. (Pubitemid 20203620)
32. Passegué E, Wagers A, Giuriato S, Anderson W, Weissman I. Global analysis of proliferation and cell cycle gene expression in the regulation of hematopoietic stem and progenitor cell fates. J Exp Med. 2005;202(11):1599-1611. (Pubitemid 41746605)
33. Scandura J, Boccuni P, Massagué J, Nimer S. Transforming growth factor beta-induced cell cycle arrest of human hematopoietic cells requires p57KIP2 up-regulation. Proc Natl Acad Sci U S A. 2004;101(42):15231-15236. (Pubitemid 39391747)
34. Kurokawa M, Mitani K, Irie K, et al. The oncoprotein Evi-1 represses TGF-beta signalling by inhibiting Smad3. Nature. 1998;394(6688):92-96. (Pubitemid 28321809)
35. Alliston T, Ko T, Cao Y, et al. Repression of bone morphogenetic protein and activin-inducible transcription by Evi-1. J Biol Chem. 2005;280(25):24227- 24237. (Pubitemid 40894644)
36. Fears S, Mathieu C, Zeleznick-Le N, Huang S, Rowley J, Nucifora G. Intergenic splicing of MDS1 and EVI1 occurs in normal tissues as well as in myeloid leukemia and produces a new member of the PR domain family. Proc Natl Acad Sci U S A. 1996;93(4):1642-1647. (Pubitemid 26075179)
37. Kouzarides T. Histone methylation in transcriptional control. Review. Curr Opin Genet Dev. 2002;12(2):198-209. (Pubitemid 34219493)
38. Trievel RC, Beach BM, Dirk LM, Houtz RL, Hurley JH. Structure and catalytic mechanism of a SET domain protein methyltransferase. Cell. 2002;111(1):91-103.
39. Nanjundan M, Nakayama Y, Cheng K, et al. Amplification of MDS1/EVI1 and EVI1, located in the 3q26.2 amplicon, is associated with favorable patient prognosis in ovarian cancer. Cancer Res. 2007;67(7):3074-3084. (Pubitemid 46724844)
40. Nitta E, Izutsu K, Yamaguchi Y, et al. Oligomerization of Evi-1 regulated by the PR domain contributes to recruitment of corepressor CtBP. Oncogene. 2005;24(40):6165-6173. (Pubitemid 43080066)
41. Lugthart S, Van Drunen E, Van Norden Y, et al. High EVI1 levels predict adverse outcome in acute myeloid leukemia: prevalence of EVI1 overexpression and chromosome 3q26 abnormalities underestimated. Blood. 2008;111(8):4329-4337.
42. Lugthart S, Groschel S, Beverloo H, et al. Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and various other 3q abnormalities in acute myeloid leukemia. J Clin Oncol. 2010;28(24):3890-3898.
43. Yan Y, Frisen J, Lee M, Massague J, Barbacid M. Ablation of the CDK inhibitor p57Kip2 results in increased apoptosis and delayed differentiation during mouse development. Genes Dev. 1997;11(8):973-983. (Pubitemid 27199877)
44. Raza A, Alvi S, Borok R, et al. Excessive proliferation matched by excessive apoptosis in myelodysplastic syndromes: the cause-effect relationship. Leuk Lymphoma. 1997;27(1-2):111-118. (Pubitemid 27482927)